Released on: February 02, 2015, 4:33 am (EST)
Author: Dr. Chris Centeno
Industry: Biotech, Healthcare
Broomfield, CO, February 02, 2015 — /EPR NETWORK/ — With more than 40,000 downloads, “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” is now available on Amazon Kindle. The third edition of the top-selling e-book is being offered as a free download through Jan. 6, 2015.
Written by Dr. Chris Centeno, this e-book delves into the human musculoskeletal system and explains how everything works together in concert to maintain our physical wellbeing. When a single component in this chain is damaged, it can lead to a cascade of joint, spine and connective tissue problems, resulting in chronic pain.
Released on: December 01, 2014, 2:30 pm (EST)
Author: ViroCarb Inc.
Industry: Biotech, Healthcare, Pharmaceuticals
Toronto, Canada, December 01, 2014 — /EPR NETWORK/ — ViroCarb Inc. has launched a worldwide crowd funding campaign to promote the development of its new HIV infection inhibitor.
WORLD AIDS DAY – Make a donation to save lives from AIDS! Support new treatment development at: https://www.indiegogo.com/projects/funding-a-new-therapy-against-drug-resistant-hiv/x/9240077
Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.
Released on: May 28, 2014, 5:11 pm (EDT)
Author: HD Biosciences Co.,Ltd.
Industry: Pharmaceuticals, Biotech
Shanghai, May 28, 2014 — /EPR NETWORK/ — HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.
Released on: November 20, 2013, 1:10 pm
Author: TCG Lifesciences Limited
November 20, 2013, 1:10 pm — /EPR NETWORK/ — Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey, US. Focus will be small molecule and biologics PR&D, innovative technology platforms, filling vial and bag operations, peptide synthesis, oligonucleotide production and related areas.
Released on: October 28, 2013, 10:18 am
Author: HD Biosciences
Industry: Biotech, Pharmaceuticals
October 28, 2013, 10:18 am — /EPR NETWORK/ — HD Biosciences Co., Ltd (HDB) and Anchor Therapeutics, Inc. today announced that they have formed a strategic collaboration to co-develop and co-market Anchor’s proprietary pepducin technology and provide novel drug development solutions to global pharmaceutical companies with drug discovery efforts focused on G-protein coupled receptors (GPCR).
Released on: October 08, 2013, 12:48 am
Author: LC Sciences
Industry: Biotech, Internet & Online
Houston, TX, October 08, 2013, 12:48 am — /EPR NETWORK/ — LC Sciences, LLC, a leading provider of microRNA analysis services, today announced the launch of a new online searchable knowledgebase that researchers can use to locate technical information on the company’s website. This announcement comes on the heels of the launch of LC Sciences’ re-designed company website last week. The knowledgebase contains technical information in the form of application notes, technical bulletins, customer publications, presentations, reviews of seminal publications in the field, etc. This documents database contains over one thousand entries and encompasses a wide range of research fields; from plant science to neuroscience. Additionally, all entries have been carefully meta-tagged to improve search results.